CRP, SAA, LDH, and DD predict poor prognosis of coronavirus disease (COVID-19): a meta-analysis from 7739 patients

References

• Pinney SP, Giustino G, Halperin JL, et al. Coronavirus historical perspective, disease mechanisms, and clinical outcomes: JACC focus seminar. J Am Coll Cardiol. 2020;76(17):1999–2010.
   PubMed Web of Science ®Google Scholar
• Chen Y, Klein SL, Garibaldi BT, et al. Aging in COVID-19: vulnerability, immunity and intervention. Ageing Res Rev. 2021;65:101205.
   PubMed Web of Science ®Google Scholar
• Wiersinga WJ, Rhodes A, Cheng AC, et al. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324(8):782–793.
   PubMed Web of Science ®Google Scholar
• Hosoki K, Chakraborty A, Sur S. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective. J Allergy Clin Immunol. 2020;146(2):285–299.
   PubMed Web of Science ®Google Scholar
• Barton LM, Duval EJ, Stroberg E, et al. COVID-19 autopsies, Oklahoma, USA. Am J Clin Pathol. 2020;153(6):725–733.
   PubMed Web of Science ®Google Scholar
• Liu F, Li L, Xu M, et al. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol. 2020;127:104370.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng KI, Liu S, et al. Plasma CRP level is positively associated with the severity of COVID-19. Ann Clin Microbiol Antimicrob. 2020;19(1):18.
   PubMed Web of Science ®Google Scholar
• Yu Y, Liu T, Shao L, et al. Novel biomarkers for the prediction of COVID-19 progression a retrospective, multi-center cohort study. Virulence. 2020;11(1):1569–1581.
   PubMed Web of Science ®Google Scholar
• Martha JW, Wibowo A, Pranata R. Prognostic value of elevated lactate dehydrogenase in patients with COVID-19: a systematic review and meta-analysis. Postgrad Med J. 2021.
   PubMed Web of Science ®Google Scholar
• Libby P. The heart in COVID-19: Primary target or secondary bystander? JACC Basic Transl Sci. 2020;5(5):537–542.
   PubMedGoogle Scholar
• Luo D, Wan X, Liu J, et al. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27(6):1785–1805.
   PubMed Web of Science ®Google Scholar
• Wan X, Wang W, Liu J, et al. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.
   PubMed Web of Science ®Google Scholar
• Aloisio E, Chibireva M, Serafini L, et al. A comprehensive appraisal of laboratory biochemistry tests as major predictors of COVID-19 severity. Arch Pathol Lab Med. 2020;144(12):1457–1464.
   PubMed Web of Science ®Google Scholar
• Bonetti G, Manelli F, Patroni A, et al. Laboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of valcamonica, Italy. Clin Chem Lab Med. 2020;58(7):1100–1105.
   PubMed Web of Science ®Google Scholar
• Chen FF, Zhong M, Liu Y, et al. The characteristics and outcomes of 681 severe cases with COVID-19 in China. J Crit Care. 2020;60:32–37.
   PubMed Web of Science ®Google Scholar
• Cheng L, Yang JZ, Bai WH, et al. Prognostic value of serum amyloid a in patients with COVID-19. Infection. 2020;48(5):715–722.
   PubMed Web of Science ®Google Scholar
• Cui N, Yan R, Qin C, et al. Clinical characteristics and immune responses of 137 deceased patients with COVID-19: a retrospective study. Front Cell Infect Microbiol. 2020;10:595333.
   PubMed Web of Science ®Google Scholar
• Dreher M, Kersten A, Bickenbach J, et al. The characteristics of 50 hospitalized COVID-19 patients with and without ARDS. Dtsch Arztebl Int. 2020;117(16):271–278.
   PubMed Web of Science ®Google Scholar
• El Aidaoui K, Haoudar A, Khalis M, et al. Predictors of severity in covid-19 patients in Casablanca, Morocco. Cureus. 2020;12(9):e10716.
   PubMed Web of Science ®Google Scholar
• Fan H, Zhang L, Huang B, et al. Cardiac injuries in patients with coronavirus disease 2019: not to be ignored. Int J Infect Dis. 2020;96:294–297.
   PubMed Web of Science ®Google Scholar
• Giacomelli A, Ridolfo AL, Milazzo L, et al. 30-day mortality in patients hospitalized with COVID-19 during the first wave of the italian epidemic: a prospective cohort study. Pharmacol Res. 2020;158:104931.
   PubMed Web of Science ®Google Scholar
• Han Y, Zhang H, Mu S, et al. Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study. Aging. 2020;12(12):11245–11258.
   PubMedGoogle Scholar
• Haroun RA, Osman WH, Eessa AM. Interferon-γ-induced protein 10 (IP-10) and serum amyloid A (SAA) are excellent biomarkers for the prediction of COVID-19 progression and severity . Life Sci. 2021;269:119019.
   PubMed Web of Science ®Google Scholar
• Huang Y, Lyu X, Li D, et al. A cohort study of 676 patients indicates D-dimer is a critical risk factor for the mortality of COVID-19. PLOS One. 2020;15(11):e0242045.
   PubMed Web of Science ®Google Scholar
• Li L, Yang L, Gui S, et al. Association of clinical and radiographic findings with the outcomes of 93 patients with COVID-19 in wuhan, China. Theranostics. 2020;10(14):6113–6121.
   PubMed Web of Science ®Google Scholar
• Li M, Cheng B, Zeng W, et al. Analysis of the risk factors for mortality in adult COVID-19 patients in Wuhan: a multicenter study. Front Med. 2020;7:545.
   PubMed Web of Science ®Google Scholar
• Liu L, Zheng Y, Cai L, et al. Neutrophil-to-lymphocyte ratio, a critical predictor for assessment of disease severity in patients with COVID-19. Int J Lab Hem. 2021;43(2):329–335.
   PubMed Web of Science ®Google Scholar
• Liu Q, Dai Y, Feng M, et al. Associations between serum amyloid A, interleukin-6, and COVID-19: a cross-sectional study. J Clin Lab Anal. 2020;34(10):e23527.
   PubMed Web of Science ®Google Scholar
• Liu SL, Wang SY, Sun YF, et al. Expressions of SAA, CRP, and FERR in different severities of COVID-19. Eur Rev Med Pharmacol Sci. 2020;24(21):11386–11394.
   PubMed Web of Science ®Google Scholar
• Chen M, Wu Y, Jia W, et al. The predictive value of serum amyloid a and C-reactive protein levels for the severity of coronavirus disease 2019. Am J Transl Res. 2020;12(8):4569–4575.
   PubMed Web of Science ®Google Scholar
• Pan F, Yang L, Li Y, et al. Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study. Int J Med Sci. 2020;17(9):1281–1292.
   PubMed Web of Science ®Google Scholar
• Paranjpe I, Russak AJ, De Freitas JK, Mount Sinai COVID Informatics Center (MSCIC), et al. Retrospective cohort study of clinical characteristics of 2199 hospitalised patients with COVID-19 in New York city. BMJ Open. 2020;10(11):e040736.
   PubMed Web of Science ®Google Scholar
• Ren L, Yao D, Cui Z, et al. Corona virus disease 2019 patients with different disease severity or age range: a single-center study of clinical features and prognosis. Medicine. 2020;99(49):e22899.
   PubMed Web of Science ®Google Scholar
• Shang W, Dong J, Ren Y, et al. The value of clinical parameters in predicting the severity of COVID-19. J Med Virol. 2020;92(10):2188–2192.
   PubMed Web of Science ®Google Scholar
• Smadja DM, Guerin CL, Chocron R, et al. Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients. Angiogenesis. 2020;23(4):611–620.
   PubMed Web of Science ®Google Scholar
• Sulejmani A, Galimberti E, Giacobone C, et al. Baseline characteristics of COVID-19 Italian patients admitted to Desio Hospital, Lombardy: a retrospective study. Scand J Clin Lab Invest. 2021;81(1):18–23.
   PubMed Web of Science ®Google Scholar
• Wan S, Xiang Y, Fang W, et al. Clinical features and treatment of COVID-19 patients in northeast Chongqing. J Med Virol. 2020;92(7):797–806.
   PubMed Web of Science ®Google Scholar
• Wang D, Li R, Wang J, et al. Correlation analysis between disease severity and clinical and biochemical characteristics of 143 cases of COVID-19 in Wuhan, China: a descriptive study. BMC Infect Dis. 2020;20(1):519.
   PubMed Web of Science ®Google Scholar
• Wang H, Xing Y, Yao X, et al. Retrospective study of clinical features of COVID-19 in inpatients and their association with disease severity. Med Sci Monit. 2020;27:e927674.
   Web of Science ®Google Scholar
• Yang Q, Xie L, Zhang W, et al. Analysis of the clinical characteristics, drug treatments and prognoses of 136 patients with coronavirus disease 2019. J Clin Pharm Ther. 2020;45(4):609–616.
   PubMed Web of Science ®Google Scholar
• Yuan X, Huang W, Ye B, et al. Changes of hematological and immunological parameters in COVID-19 patients. Int J Hematol. 2020;112(4):553–559.
   PubMed Web of Science ®Google Scholar
• Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan. China. Allergy. 2020;75(7):1730–1741.
   PubMed Web of Science ®Google Scholar
• Zhou J, Sun J, Cao Z, et al. Epidemiological and clinical features of 201 COVID-19 patients in Changsha city, Hunan, China. Medicine. 2020;99(34):e21824.
   PubMed Web of Science ®Google Scholar
• Zou L, Dai L, Zhang Y, et al. Clinical characteristics and risk factors for disease severity and death in patients with coronavirus disease 2019 in Wuhan, China. Front Med. 2020;7:532.
   PubMed Web of Science ®Google Scholar
• Zhang ZL, Hou YL, Li DT, et al. Laboratory findings of COVID-19: a systematic review and meta-analysis. Scand J Clin Lab Invest. 2020;80(6):441–447.
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062.
   PubMed Web of Science ®Google Scholar
• Liang W, Liang H, Ou L, China Medical Treatment Expert Group for COVID-19, et al. Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19. JAMA Intern Med. 2020;180(8):1081–1089.
   PubMed Web of Science ®Google Scholar
• Gao Y, Li T, Han M, et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol. 2020;92(7):791–796.
   PubMed Web of Science ®Google Scholar
• Piotti KC, Yantiss RK, Chen Z, et al. Serum amyloid a immunohistochemical staining patterns in hepatitis. Histopathology. 2016;69(6):937–942.
   PubMed Web of Science ®Google Scholar
• Li H, Xiang X, Ren H, et al. Serum amyloid a is a biomarker of severe coronavirus disease and poor prognosis. J Infect. 2020;80(6):646–655.
   PubMed Web of Science ®Google Scholar
• Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003;289(21):2801–2809.
   PubMed Web of Science ®Google Scholar
• Hoeboer SH, Oudemans-van Straaten HM, Groeneveld AB. Albumin rather than C-reactive protein may be valuable in predicting and monitoring the severity and course of acute respiratory distress syndrome in critically ill patients with or at risk for the syndrome after new onset fever. BMC Pulm Med. 2015;15:22.
   PubMed Web of Science ®Google Scholar
• Laguna-Goya R, Utrero-Rico A, Talayero P, et al. IL-6-based mortality risk model for hospitalized patients with COVID-19. J Allergy Clin Immunol. 2020;146(4):799–807 e9.
   PubMed Web of Science ®Google Scholar
• Holshue ML, DeBolt C, Lindquist S, Washington State 2019-nCoV Case Investigation Team, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020;382(10):929–936.
   PubMed Web of Science ®Google Scholar
• Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-Infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069.
   PubMed Web of Science ®Google Scholar